In a nutshell This study evaluated how well palbociclib (Ibrance) works in patients with breast cancer who received multiple lines of previous therapy. This study found that palbociclib was effective for these patients. Some background There are several different treatments for breast cancer depending on the types of...
Read MoreTreatment(s) already received-Experimental drug Posts on Medivizor
Can we predict high-intensity focused ultrasound success before treatment?
In a nutshell This paper studied factors that might influence prostate-specific antigen (PSA) nadir levels following high-intensity ultrasound treatment in patients whose cancer has not spread beyond the prostate. Some background High-intensity focused ultrasound (HIFU) is a primary treatment in prostate cancer that targets and removes damaged or...
Read MoreLinking the number of metastases to outlook in prostate cancer
In a nutshell This study attempted to examine the contribution of different components of prostate cancer on the outlook of patients diagnosed with metastatic disease despite treatment. Some background In some cases of prostate cancer, the primary treatment does not cure the disease, and metastases (cancer lesions in other body parts)...
Read MorePhase II clinical trial evaluating the combination of cetuximab and erlotinib for the treatment of patients with metastatic colorectal cancer
In a nutshell This article presents the results of a phase II clinical trial that evaluated the efficacy and safety of the combination of two targeted therapies – cetuximab and erlotinib – for patients with metastatic colorectal cancer (mCRC). Some background Colorectal cancer that has spread outside the large...
Read More